Dr. Mary Elizabeth Sehl, MD

Dr. Sehl practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. Sehl's NPI, 1447403076, was assigned on October 28, 2008. Dr. Sehl graduated from The Warren Alpert Medical School of Brown University in 2001. Dr. Sehl holds California license A83888.

Dr. Sehl's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. Sehl's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. Dr. Sehl is also affiliated with UCLA Santa Monica Medical Center. The medical group on file is UCLA Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sehl practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Sehl's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Sehl is board certified in medical oncology by the American Board of Internal Medicine. Dr. Sehl is licensed in California.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lymphoma and multiple myeloma among the conditions Dr. Sehl treats.

CMS data shows 5,970 Medicare services from Dr. Sehl across 29 procedure codes in 2024, for 469 Medicare patients. Medicare paid $273,856 for them.

CMS counts 469 Medicare patients who saw Dr. Sehl in 2024. The largest group is 65 to 74, with 209 patients. 74% of them have high blood pressure, and 74% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sehl's median patient age at 56, with 57% women.

In 2024, Dr. Sehl wrote 152 Medicare Part D claims for 28 patients. 64% of them were for generic drugs. CMS names the drug for 58 of them, across 4 drugs with 11 or more claims each, at $187,370 in total drug cost. In 2023, CMS named 53 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Sehl for performance year 2024, reported as part of a group. Dr. Sehl accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sehl as offering telehealth.

Dmand AI links 31 papers to Dr. Sehl, published from 2010 to 2025. 2021 was the busiest year, with 4. The most frequent topics are Models, Biological, Stochastic Processes and Computer Simulation. Dr. Sehl has published most often in PLoS One. Dr. Sehl's most frequent co-authors are Steven Wolinsky, MD, Roger Yi Wei Shih, MD and Jason Jin Xu, MD.

CMS Open Payments shows 1 general payment to Dr. Sehl from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Terumo BCT, Inc. paid the most, $120.

Dr. Sehl graduated from The Warren Alpert Medical School of Brown University in 2001.

Dr. Sehl is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.